vimarsana.com

Latest Breaking News On - Orsay kang - Page 1 : vimarsana.com

被严重低估的创新药潜力股?————东方财富网博客

被严重低估的创新药潜力股?————东方财富网博客
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.

被严重低估的创新药潜力股?————东方财富网博客

被严重低估的创新药潜力股?————东方财富网博客
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.

386股中报报喜 130股增长超1倍- CFi CN 中财网

386股中报报喜 130股增长超1倍- CFi CN 中财网
cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.

奥赛康上半年营收增长11% 5个新品获准上市 _ 东方财富网

奥赛康上半年营收增长11% 5个新品获准上市 _ 东方财富网
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.

奥赛康:上半年净利润同比增长15 39% 研发投入超2亿元 _ 东方财富网

8月29日晚间,奥赛康(002755)发布2021年半年度报告。报告期内,公司实现营业总收入167405万元,同比增长11.43%;实现归母净利润26317万元,同比增长15.39%;研发投入达到20661万元,占营业收入12.34%,重点聚焦小分子靶向创新药物、肿瘤免疫领域生物创新药研发。

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.